{
    "2019-12-30": [
        [
            {
                "time": "",
                "original_text": "恒瑞医药获得SHR-1316注射液临床试验通知",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR-1316",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "全国第二批药品集中采购启动，生物医药板块整体翻红",
                "features": {
                    "keywords": [
                        "集中采购",
                        "生物医药",
                        "翻红"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "今年17款重磅药获批上市，市场竞争激烈",
                "features": {
                    "keywords": [
                        "重磅药",
                        "获批",
                        "市场竞争"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中航证券：继续围绕创新药产业链、医疗消费布局",
                "features": {
                    "keywords": [
                        "中航证券",
                        "创新药",
                        "医疗消费"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "第二批集采文件落地，政策有所缓和但预计价格搏杀依旧激烈",
                "features": {
                    "keywords": [
                        "第二批集采",
                        "政策",
                        "价格搏杀"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "突发！华兰生物闪崩市值蒸发40亿！9家医药白马股暴雷！",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "闪崩",
                        "暴雷"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "第二批带量采购计划落地，生产注射剂企业业绩或承压盈利能力下降",
                "features": {
                    "keywords": [
                        "带量采购",
                        "注射剂",
                        "盈利能力"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "科技龙头ETF单日获亿级资金涌入，最新规模达69.5亿元再创历史新高",
                "features": {
                    "keywords": [
                        "科技龙头ETF",
                        "资金涌入",
                        "规模"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "年底，NMPA新药三连发！",
                "features": {
                    "keywords": [
                        "NMPA",
                        "新药",
                        "三连发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "第二批药品带量采购启动，创新药和器械有望正式崛起",
                "features": {
                    "keywords": [
                        "带量采购",
                        "创新药",
                        "器械"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：瑞马唑仑获批准丰富麻醉管线，有望成为15亿品种贡献新增量",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "瑞马唑仑",
                        "麻醉管线"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "百济神州PD-1药物获批，“四大国产单抗”已齐聚",
                "features": {
                    "keywords": [
                        "百济神州",
                        "PD-1",
                        "国产单抗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}